1.Isolation and antimocrobial susceptibility of bacteroides fragilis.
Kag Hyun KIM ; Hyung Hoan LEE ; Hye Kyung CHUNG
Journal of the Korean Society for Microbiology 1992;27(2):115-123
No abstract available.
Bacteroides fragilis*
;
Bacteroides*
2.In vitro susceptibilities of bacteroides fragilis group organisms: comparison of the strains isolated in 1990 with 1991.
Kyung Won LEE ; Yoon Seob JUNG ; Oh Hun KWON ; In Ho CHANG ; Kap Joon YOON ; Sung Jin KIM
Korean Journal of Infectious Diseases 1993;25(1):27-32
No abstract available.
Bacteroides fragilis*
;
Bacteroides*
3.Genetic Structure in the Region Near the Sialidase Gens in Bacteroides fragilis.
Tomomi KUWAHARA ; Haruyuki NAKAYAMA ; Tomoya IWASA ; Suya OKAMOTO ; Yuuki TSUCHIHASHI ; Yoshinari OHNISHI
Journal of the Korean Society for Microbiology 2000;35(5):364-364
No Abstract Available.
Bacteroides fragilis*
;
Bacteroides*
;
Genetic Structures*
;
Neuraminidase*
4.Nuclear Factor - kappa B Activation and Signal Transduction Pathway in Human Intestinal Epithelial Cells Stimulated with Bacteroides fragilis Enterotoxin.
Jung Mogg KIM ; Soo Jin CHO ; Shin Jae KANG ; Hwoon Yong JUNG ; Yu Kyoung OH ; Young Jeon KIM ; Yang Ja CHO
Journal of Bacteriology and Virology 2001;31(4):343-351
No abstract available.
Bacteroides fragilis*
;
Bacteroides*
;
Enterotoxins*
;
Epithelial Cells*
;
Humans*
;
Signal Transduction*
5.Using FAB and PYG in coordinating with PCR on culturing, isolating and identifying enterotoxigenic bacteroides fragilis
Journal of Practical Medicine 2005;0(12):42-44
The result of the study of using FAB and PYG in isolation and identification of ETBF from fecal samples were as follows: FAB medium had more advantages as compared to PYG. Together with using FAB, the PCR method can differentiate and identity ETBF from the B. fragilis species. The detection limit of PCR was 103 CFU of bacteria per ml of fecal suspension. Among 27 B. fragilis trains, 66% of them were positive with primer pair GBF 201-210 by PCR. The findings showed that ETBF can be detected by culturing samples in FAB together with identification by PCR. More studies could be done for detecting ETBF from fecal samples, especially from diarrhea patients
Bacteroides fragilis
;
Polymerase Chain Reaction
6.Bacteroides nordii and Bacteroides salyersiae Isolated from Post-operative Peritonitis Patients.
Jihoon G YOON ; Hyunsoo KIM ; Yangsoon LEE ; Myungsook KIM ; Dongeun YONG ; Seok Hoon JEONG ; Kyungwon LEE
Laboratory Medicine Online 2016;6(2):111-115
In this study, we report three cases in which two species of the Bacteroides fragilis group, 'Bacteroides nordii' and 'Bacteroides salyersiae', were isolated from peritoneal fluid cultures from post-operative peritonitis patients. The two species of the B. fragilis group were initially misidentified as B. fragilis/Bacteroides stercoris and Bacteroides ovatus by Rapid ID 32A (bioMérieux, France), and finally confirmed as B. nordii and B. salyersiae using matrix-assisted laser desorption ionization-time of flight mass spectrometry (MALDI-TOF MS) and 16s rRNA sequencing. For the identification of anaerobes, particularly B. fragilis group organisms, MALDI-TOF MS is a useful method not only because of its concordance with 16S rRNA sequencing results, but also because of its rapidity and simple procedure.
Ascitic Fluid
;
Bacteroides fragilis
;
Bacteroides*
;
Humans
;
Mass Spectrometry
;
Peritonitis*
;
Spectrum Analysis
7.Inflammatory Reaction in Intestinal Mucosa by Bacteroides fragilis Enterotoxin Stimulation: Regulation of Chemokine Gene Expression in Human Intestinal Epithelial Cells.
Jung Mogg KIM ; Soo Jin CHO ; Yu Kyoung OH ; Hee Bok OH ; Yang Ja CHO
Journal of Bacteriology and Virology 2001;31(2):113-121
No abstract available.
Bacteroides fragilis*
;
Bacteroides*
;
Enterotoxins*
;
Epithelial Cells*
;
Gene Expression*
;
Humans*
;
Intestinal Mucosa*
8.Basolaterial Secretion of CXC Chemokines by Human Intestinal Epithelial Cells in Response to Bacteroides fragilis Enterotoxin Via NF-kB Pathway.
Jung Mogg KIM ; Yu Kyoung OH ; Young Jeon KIM ; Hee Bok OH ; Yang Ja CHO
Journal of the Korean Society for Microbiology 2000;35(5):350-350
No Abstract Available.
Bacteroides fragilis*
;
Bacteroides*
;
Chemokines, CXC*
;
Enterotoxins*
;
Epithelial Cells*
;
Humans*
;
NF-kappa B*
9.Basolaterial Secretion of CXC Chemokines by Human Intestinal Epithelial Cells in Response to Bacteroides fragilis Enterotoxin Via NF-kB Pathway.
Jung Mogg KIM ; Yu Kyoung OH ; Young Jeon KIM ; Hee Bok OH ; Yang Ja CHO
Journal of the Korean Society for Microbiology 2000;35(5):350-350
No Abstract Available.
Bacteroides fragilis*
;
Bacteroides*
;
Chemokines, CXC*
;
Enterotoxins*
;
Epithelial Cells*
;
Humans*
;
NF-kappa B*
10.Comparison of the E-test with agar dilution susceptibility test by using bacteroides fragilis.
Hee Sun KIM ; Sung Kwang KIM ; Hwa Sun CHA
Yeungnam University Journal of Medicine 1993;10(1):135-143
The susceptibilities of 45 clinical isolates of bacteroidis fragilis to cefaclor, ciproflxacin and imipenem were determined by new method, E-test (AB Bidisk, Solna, Sweden) and were compared with those from conventional agar dilution method by using brain heart infusion, Mueller-Hinton and Wilk:..s Chalgren agar plates. And the susceptibility of 60 clinical isolates of bacteroides fragilis group (B. fragilis 45 strains, B. distasonis 6 strains, B. ovatus 5 strains, B. thetaiotaomicron 4 strains) to 5 quinolones (ciprofloxacin, enoxacin, norfloxacin, ofloxacin, pefloxacin) were determined by in vitro agar dilution method. Compared with agar dilution MICs for B. fragilis 45 strains, 90.3% of E-test MICs were within +/- 1 dilution of the agar dilutions, and 98.4% were within 2 dilutions. And there were little effect of different medium bases to determine MICs except Mueller-Hinton agar. On Mueller-Hinton agar, B. fragilis showed have or no growth activity. In vitro susceptibility of B. fragilis group to quinolones, most of the test strains showed resistant patterns to quinolones except ofloxacin and there was little difference of susceptibility patterns between species of B. fragilis group.
Agar*
;
Bacteroides fragilis*
;
Bacteroides*
;
Brain
;
Cefaclor
;
Enoxacin
;
Heart
;
Imipenem
;
Norfloxacin
;
Ofloxacin
;
Quinolones
Result Analysis
Print
Save
E-mail